Viewing Study NCT07038005


Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2026-01-01 @ 3:58 AM
Study NCT ID: NCT07038005
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-26
First Post: 2025-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-07-13
Start Date Type: ESTIMATED
Primary Completion Date: 2026-09-22
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-06-08
Completion Date Type: ESTIMATED
First Submit Date: 2025-06-17
First Submit QC Date: None
Study First Post Date: 2025-06-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-06-25
Last Update Post Date: 2025-06-26
Last Update Post Date Type: ACTUAL